Flinton Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $694K | Sell |
7,084
-476
| -6% | -$46.6K | 0.02% | 377 |
|
|
2019
Q2 | $990K | Sell |
7,560
-2,576
| -25% | -$337K | 0.03% | 324 |
|
|
2019
Q1 | $1.37M | Buy |
10,136
+2,492
| +33% | +$337K | 0.05% | 252 |
|
|
2018
Q4 | $744K | Sell |
7,644
-140
| -2% | -$13.6K | 0.03% | 326 |
|
|
2018
Q3 | $1.08M | Buy |
7,784
+84
| +1% | +$11.7K | 0.03% | 306 |
|
|
2018
Q2 | $956K | Buy |
7,700
+1,036
| +16% | +$129K | 0.03% | 314 |
|
|
2018
Q1 | $743K | Sell |
6,664
-280
| -4% | -$31.2K | 0.02% | 335 |
|
|
2017
Q4 | $831K | Buy |
6,944
+1,932
| +39% | +$231K | 0.03% | 323 |
|
|
2017
Q3 | $703K | Sell |
5,012
-896
| -15% | -$126K | 0.03% | 329 |
|
|
2017
Q2 | $719K | Buy |
5,908
+476
| +9% | +$57.9K | 0.03% | 313 |
|
|
2017
Q1 | $658K | Buy |
5,432
+840
| +18% | +$102K | 0.03% | 319 |
|
|
2016
Q4 | $562K | Buy |
+4,592
| New | +$562K | 0.02% | 313 |
|